NCT06214676

Brief Summary

Is to investigate retinal microvascular changes in primary open angle glaucoma patients using Optical Coherence Tomography Angiography.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 19, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
Last Updated

March 7, 2024

Status Verified

March 1, 2024

Enrollment Period

9 months

First QC Date

January 10, 2024

Last Update Submit

March 5, 2024

Conditions

Open Angle Glaucoma

Outcome Measures

Primary Outcomes (1)

  • to detect and evaluate microvascular changes in primary open angle glaucoma both qualitatively and quantitatively.

    Detection of microvascular changes in patients with Primary open-angle glaucoma

    Baseline

Interventions

OCT angiographyDEVICE

Detection of microvascular changes in patients with primary open angle glaucoma by using Optical Coherence Tomography Angiography

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Primary open angle patients presented to El Nour Eye Center data will be collected by scientifically qualified and trained resident doctors using Optical Coherence Tomography Angiography ( solix)

You may qualify if:

  • \- clinical diagnosis of Primary open angle glaucoma.

You may not qualify if:

  • media opacity
  • poor fixation due to advanced disease
  • associated vascular retinopathy
  • chronic uveitis
  • optic nerve disease due to other etiologies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Glaucoma, Open-Angle

Condition Hierarchy (Ancestors)

GlaucomaOcular HypertensionEye Diseases

Central Study Contacts

Yara Ahmed

CONTACT

01062165361ayara1942@gmail.com

Abd El Nasser Mohammad

CONTACT

01064747230abdelnasser@aun.edu.eg

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor at internal ophthalmology department

Study Record Dates

First Submitted

January 10, 2024

First Posted

January 19, 2024

Study Start

April 1, 2024

Primary Completion

January 1, 2025

Study Completion

February 1, 2025

Last Updated

March 7, 2024

Record last verified: 2024-03